secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autonomix Medical, Inc. (AMIX)
CIK:        0001617867
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001437749-26-000937
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autonomix reports pancreatic cancer pain relief across all stages in PoC study at ASCO GI 2026
--------------------------------------------------------------------------------

- Rapid pain reduction within 24 hours of transvascular RF denervation procedure.
- At 7 days, 93.75% of responding patients (N=16) improved from severe to mild/moderate pain.
- At 4-6 weeks, ~2/3 of responders (N=9) maintained mild or eliminated pain levels.
- At 3 months, no responders (N=6) had severe pain; 50% maintained mild or eliminated pain.
- Even late-stage (Stage 4) patients showed meaningful early improvement despite disease progression.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617867/000143774926000937/0001437749-26-000937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617867/000143774926000937/amix20260108_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-000937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer